SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Cognition Studio, Inc.

Moderna's mRNA Nanoparticle Platform 

Prev Next
Previous

SARS-CoV-2 Close-up View of the Spike Protein

medical illustration of Cognition created this editorialized visualization of an mRNA delivery nanoparticle platform for an Investor Day presentation by Moderna. The nanoparticle is intended to showcase the elegant complexity of Moderna’s engineering and to make the system feel tangible and real to the audience. 

Visit https://cognitionstudio.com/expertise/moderna/ to see the case study.
Next medical illustration of Researchers at the UW Institute for Protein Design (IPD) are revolutionizing how new de novo protein drugs, or “mini-protein binders,” can be generated. To support their publication and media efforts, Cognition created this editorial visualization to highlight their integration of computational design and laboratory testing, which rapidly generates and evaluates thousands of binders to find the best conformation to neutralize a specific target, such as hemagglutinin on the flu virus.

Mini-Protein Binder Designs Against the Flu Virus

Cognition created this editorialized visualization of an mRNA delivery nanoparticle platform for an Investor Day presentation by Moderna. The nanoparticle is intended to showcase the elegant complexity of Moderna’s engineering and to make the system feel tangible and real to the audience. Visit https://cognitionstudio.com/expertise/moderna/ to see the case study.

Keywords: Color, 3D, Advertising / Marketing, Editorial, Education, Technology, Biology, Biotechnology, Genetics, Molecular Biology

Moderna Therapeutics